Physician Data Query

Last uploaded: January 31, 2024
Preferred Name

alitretinoin

Synonyms

ALRT1057

Definitions

An orally- and topically-active naturally-occurring retinoic acid with antineoplastic, chemopreventive, teratogenic, and embryotoxic activities. Alitretinoin binds to and activates nuclear retinoic acid receptors (RAR) and retinoid X receptors (RXR); these activated receptors act as transcription factors, regulating gene expression that results in the inhibition of cell proliferation, induction of cell differentiation, and apoptosis of both normal cells and tumor cells. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1574" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1574" NCI Thesaurus)

ID

http://purl.bioontology.org/ontology/PDQ/CDR0000042147

altLabel

ALRT1057

9-CRA

9-cis Retinoic Acid

Panretyn

Panretin

Panrexin

3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-trans-4-trans-6-cis-8-trans-nonatetraenoic Acid

3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-cis-4-trans-6-trans-8-trans-nonatetraenoic Acid

9-cis-retinoic acid

LGD1057

9-cis-RA

CAS Registry

5300-03-8

Component of

http://purl.bioontology.org/ontology/PDQ/CDR0000042368

http://purl.bioontology.org/ontology/PDQ/CDR0000042510

http://purl.bioontology.org/ontology/PDQ/CDR0000042329

cui

C1510846

C1510845

C0281666

C0722482

C0918022

C0022265

C0918021

Date last modified

2008-02-26

definition

An orally- and topically-active naturally-occurring retinoic acid with antineoplastic, chemopreventive, teratogenic, and embryotoxic activities. Alitretinoin binds to and activates nuclear retinoic acid receptors (RAR) and retinoid X receptors (RXR); these activated receptors act as transcription factors, regulating gene expression that results in the inhibition of cell proliferation, induction of cell differentiation, and apoptosis of both normal cells and tumor cells. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1574" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1574" NCI Thesaurus)

IND Code

48234

Legacy PDQ ID

5384

LT

TRD

NCI ID

C1574

notation

CDR0000042147

NSC Code

659772

ORIG STY

Drug/agent

prefLabel

alitretinoin

tui

T109

T127

T121

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
http://purl.bioontology.org/ontology/ATC/L01XF02 ATC CUI
http://purl.bioontology.org/ontology/RXNORM/219098 RXNORM CUI
http://purl.bioontology.org/ontology/VANDF/4017801 VANDF CUI
http://purl.bioontology.org/ontology/NDFRT/N0000006664 NDFRT CUI
http://purl.bioontology.org/ontology/MESH/D000077556 MESH CUI
http://purl.bioontology.org/ontology/SNOMEDCT/116086005 SNOMEDCT CUI
http://purl.bioontology.org/ontology/NDFRT/N0000148606 NDFRT CUI
http://purl.bioontology.org/ontology/ATC/D11AH04 ATC CUI
http://purl.bioontology.org/ontology/SCTSPA/116086005 SCTSPA CUI
http://purl.bioontology.org/ontology/RXNORM/81864 RXNORM CUI
http://purl.bioontology.org/ontology/SNOMEDCT/409488005 SNOMEDCT CUI
http://purl.bioontology.org/ontology/NDDF/007747 NDDF CUI
http://purl.bioontology.org/ontology/SCTSPA/409488005 SCTSPA CUI
http://purl.bioontology.org/ontology/MSHFRE/D000077556 MSHFRE CUI
http://purl.bioontology.org/ontology/VANDF/4021155 VANDF CUI
http://purl.bioontology.org/ontology/MESH/D000077556 MESH CUI
http://purl.bioontology.org/ontology/ATC/D10AD04 ATC CUI
http://purl.bioontology.org/ontology/MESH/D015474 MESH CUI
http://purl.bioontology.org/ontology/SCTSPA/387208003 SCTSPA CUI
http://purl.bioontology.org/ontology/NDFRT/N0000146162 NDFRT CUI
http://purl.bioontology.org/ontology/LNC/LP17250-9 LOINC CUI
http://purl.bioontology.org/ontology/ATC/D10BA01 ATC CUI
http://purl.bioontology.org/ontology/MSHFRE/D015474 MSHFRE CUI
http://purl.bioontology.org/ontology/SCTSPA/38314008 SCTSPA CUI
http://purl.bioontology.org/ontology/NDFRT/N0000007197 NDFRT CUI
http://purl.bioontology.org/ontology/RCD/m72.. RCD CUI
http://purl.bioontology.org/ontology/NDDF/001961 NDDF CUI
http://purl.bioontology.org/ontology/SNOMEDCT/38314008 SNOMEDCT CUI
http://purl.bioontology.org/ontology/SNOMEDCT/387208003 SNOMEDCT CUI
http://purl.bioontology.org/ontology/SNMI/C-90050 SNMI CUI
http://purl.bioontology.org/ontology/RXNORM/6064 RXNORM CUI
http://purl.bioontology.org/ontology/CSP/3147-4297 CRISP CUI
http://purl.bioontology.org/ontology/LNC/MTHU060990 LOINC CUI
http://purl.obolibrary.org/obo/CHEBI_50648 BIOMODELS LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#27396 OCHV LOOM
http://www.phoc.org.cn/pmo/class/PMO_00025662 PMAPP-PMO LOOM
http://purl.obolibrary.org/obo/DRON_00013988 PDRO LOOM
http://purl.bioontology.org/ontology/ATC/L01XF02 ATC LOOM
http://purl.bioontology.org/ontology/MESH/D000077556 MESH LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#C103303 RH-MESH LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/116086005 SNOMEDCT LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000148606 NDFRT LOOM
http://www.drugbank.ca/drugs/DB00523 FTC LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0281666 OCHV LOOM
http://purl.bioontology.org/ontology/ATC/D11AH04 ATC LOOM
http://purl.bioontology.org/ontology/RXNORM/81864 RXNORM LOOM
http://purl.obolibrary.org/obo/NCIT_C1574 BERO LOOM
http://purl.bioontology.org/ontology/NDDF/007747 NDDF LOOM
https://go.drugbank.com/drugs/DB00523 MDM LOOM
http://purl.bioontology.org/ontology/VANDF/4021155 VANDF LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1574 NCIT LOOM